Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Planas, D; Bruel, T; Grzelak, L; Guivel-Benhassine, F; Staropoli, I; Porrot, F; Planchais, C; Buchrieser, J; Rajah, MM; Bishop, E; Albert, M; Donati, F; Prot, M; Behillil, S; Enouf, V; Maquart, M; Smati-Lafarge, M; Varon, E; Schortgen, F; Yahyaoui, L; Gonzalez, M; De Seze, JM; Pere, H; Veyer, D; Seve, A; Simon-Loriere, E; Fafi-Kremer, S; Stefic, K; Mouquet, H; Hocqueloux, L; van der Werf, S; Prazuck, T; Schwartz, O

Schwartz, O (corresponding author), Inst Pasteur, Dept Virol, Virus & Immun Unit, Paris, France.; Schwartz, O (corresponding author), CNRS UMR 3569, Paris, France.; Schwartz, O (corresponding author), Vaccine Res Inst, Creteil, France.

NATURE MEDICINE, ; ():

Abstract

Sera from convalescent individuals with coronavirus disease 2019 and from individuals vaccinated with BNT162b2 have reduced ability to neutralize SARS......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索